NCT00914862View on ClinicalTrials.gov

Pharmacokinetic and Safety of Ramelteon Between Adolescents With Insomnia and Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

March 31, 2011

Study Completion Date

April 30, 2011

Conditions
Insomnia
Interventions
DRUG

Ramelteon

Ramelteon tablets, orally for one day only.

Trial Locations (2)

Unknown

Overland Park

Kalamazoo

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT00914862 - Pharmacokinetic and Safety of Ramelteon Between Adolescents With Insomnia and Healthy Adults | Biotech Hunter | Biotech Hunter